Evidence map›Paper›PMID 40576634›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025

The Translational Research Program in Cancer Differences across Populations.

Jane C Figueiredo, Diana Redwood, Li Li, Elizabeth Donato, Daniel Fort, Eric E Fox, William M Grady, Heather Green, Tabitha A Harrison, Carl Haupt and 29 more

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. The Phylum Fusobacteriota Is Associated with Colorectal Cancer-Specific Mortality: Results from the Translational Research Program in Cancer Differences across Populations.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors.

Jane C FigueiredoCedars-Sinai Medical Center, Los Angeles, California.ORCID 0000-0001-8040-3341
Diana RedwoodAlaska Native Tribal Health Consortium, Anchorage, Alaska.ORCID 0000-0003-0360-5729
Li LiOchsner Health, New Orleans, Louisiana.ORCID 0000-0003-4841-2330
Elizabeth DonatoFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0009-0002-4517-8278
Daniel FortOchsner Health, New Orleans, Louisiana.ORCID 0000-0002-3759-4063
Eric E FoxTRPCDP Community Advisory Board.ORCID 0009-0004-1936-8566
William M GradyFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0000-0002-0129-7809
Heather GreenOchsner Health, New Orleans, Louisiana.ORCID 0000-0002-2389-7119
Tabitha A HarrisonUniversity of Washington, Seattle, Washington.ORCID 0000-0002-4173-7530
Carl HauptOchsner Health, New Orleans, Louisiana.ORCID 0009-0009-7249-2482
Li HsuFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0000-0001-8168-4712
Meredith A J HullarFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0000-0002-5322-9568
Jeroen R HuygheFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0000-0001-6027-9806
Wenora JohnsonTRPCDP Community Advisory Board.ORCID 0000-0003-4535-8391
Amanda L KoehneFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0000-0002-1397-6964
Scott D LaBrieFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0000-0003-0412-0731
Meredith A LakeyOchsner Health, New Orleans, Louisiana.ORCID 0009-0004-1764-2242
MingGang LinFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0009-0003-6134-8596
Nicole C LoroñaCedars-Sinai Medical Center, Los Angeles, California.ORCID 0000-0002-8302-3157
Grace A MareshOchsner Health, New Orleans, Louisiana.ORCID 0009-0000-6875-1132
Marc MatranaOchsner Health, New Orleans, Louisiana.ORCID 0000-0002-7301-170X
Jonathan D MizrahiOchsner Health, New Orleans, Louisiana.ORCID 0000-0002-3710-9742
Sarah H NashUniversity of Iowa, Iowa City, Iowa.ORCID 0000-0002-9038-6001
Nathalie T NguyenCedars-Sinai Medical Center, Los Angeles, California.ORCID 0009-0001-4282-103X
Jennifer L ParuchOchsner Health, New Orleans, Louisiana.ORCID 0000-0003-0668-1890
Amanda I PhippsUniversity of Washington, Seattle, Washington.ORCID 0000-0002-1446-2201
Conghui QuFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0000-0003-1927-6245
Timothy W RandolphFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0000-0001-8465-1588
Stephanie RomoCedars-Sinai Medical Center, Los Angeles, California.ORCID 0009-0009-0698-7153
Claire E ThomasFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0000-0001-9515-3277
Sushma ThomasFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0009-0008-7499-8068
James TiesingaAlaska Native Tribal Health Consortium, Anchorage, Alaska.ORCID 0009-0004-7099-6015
Charles WhitlowOchsner Health, New Orleans, Louisiana.ORCID 0000-0001-6750-3356
Cecilia C S YeungFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0000-0001-6799-2022
Hang YinFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0000-0002-3187-8874
Craig M ZibilichOchsner Health, New Orleans, Louisiana.ORCID 0009-0000-9004-5525
Christopher I LiFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0000-0003-1543-0743
Timothy K ThomasAlaska Native Tribal Health Consortium, Anchorage, Alaska.ORCID 0000-0001-9958-8411
Ulrike PetersFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0000-0001-5666-9318

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
Translational Research Program in Cancer Differences across PopulationsP50CA285275 · NCI · FRED HUTCHINSON CANCER CENTER · PI ULRIKE PETERS · 2024 to 2026
$9.9M
Adding Hispanics to Ongoing GWAS in Colorectal CancerR01CA155101 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI FIGUEIREDO, JANE C. · 2011 to 2015
$4.5M
Contributing Factors and Consequences of Cancer Health DisparitiesT32CA094880 · NCI · UNIVERSITY OF WASHINGTON · PI Christopher I Li, AMANDA IRENE PHIPPS · 2017 to 2026
$3.7M
Variation in tumor-associated immune profiles and colorectal cancer outcomesR01CA248931 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI SCHMIT, STEPHANIE L. · 2021 to 2025
$3.5M
Translational Research Program in Colorectal Cancer DisparitiesP20CA252733 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PIERCE, ROBERT H · 2020 to 2022
$3.4M
Biological determinants of colorectal cancer outcomes in Latinos of diverseýancestral originsR01CA238087 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI FIGUEIREDO, JANE C., SCHMIT, STEPHANIE L. · 2019 to 2024
$3.2M
Bacterial correlates of colorectal cancer subgroups and survivalR01CA217970 · NCI · UNIVERSITY OF WASHINGTON · PI PHIPPS, AMANDA IRENE · 2018 to 2022
$3.2M
Deep molecular and cellular profiling of colorectal cancer tumor and immune microenvironment in Alaska Native peopleR01CA280639 · NCI · FRED HUTCHINSON CANCER CENTER · PI Jeroen R Huyghe, ULRIKE PETERS · 2023 to 2026
$2.8M
Elucidating the role of transcriptomics in driving ethnicity and ancestry-related disparities in colorectal cancerR01CA284732 · NCI · CEDARS-SINAI MEDICAL CENTER · PI Jane C. Figueiredo, Jennifer Ann Freedman · 2024 to 2026
$2.0M
Building a Cancer Epidemiology Cohort to Investigate Factors Associated with Higher Risk of Colorectal Cancer among Alaska Native PeopleU01CA290673 · NCI · ALASKA NATIVE TRIBAL HEALTH CONSORTIUM · PI DIANA REDWOOD · 2024 to 2026
$1.3M
Fred Hutchinson Cancer Center (FHCRC) P30CA015704Goldman Sachs FoundationNational Cancer Institute (NCI) P20CA252733National Cancer Institute (NCI) P50CA285275National Cancer Institute (NCI) R01CA155101National Cancer Institute (NCI) R01CA238087National Cancer Institute (NCI) R01CA248931National Cancer Institute (NCI) R01CA280639National Cancer Institute (NCI) R01CA284732National Cancer Institute (NCI) U01CA290673NCI NIH HHS P20 CA252733NCI NIH HHS P30 CA015704NCI NIH HHS P50 CA285275NCI NIH HHS R01 CA155101NCI NIH HHS R01 CA217970NCI NIH HHS R01 CA238087NCI NIH HHS R01 CA248931NCI NIH HHS R01 CA280639NCI NIH HHS R01 CA284732NCI NIH HHS T32 CA094880NCI NIH HHS U01 CA290673V Foundation
6 · The paper itself

Abstract

backgroundCancer incidence and mortality vary substantially across populations. The Translational Research Program in Cancer Differences across Populations (TRPCDP) was established in 2020 to address differences in cancer incidence and mortality rates within the United States, with a particular focus on colorectal cancer.

methodsThe TRPCDP centralized data acquisition and harmonization across three sites in the United States to create a well-annotated resource of colorectal cancer tumors across four populations: African American/Black, Alaska Native, Hispanic/Latino/Latina, and non-Hispanic White. Using a case-control framework, patients with lethal colorectal cancer were matched to two controls with nonlethal colorectal cancer. Formalin-fixed, paraffin-embedded tumor and normal tissue were retrieved and sent for centralized pathology review, followed by DNA and RNA extraction and tissue microarray development. Multiomics and spatial profiling are underway to evaluate the transcriptome, proteome, and microbiome. Patient demographic and clinical data were obtained by medical record review, patient self-report, or linkage to cancer registries. Additional health-related factors were assessed using geospatial linkage.

resultsThe virtual biorepository includes 7,181 patients [African American (n = 1,345), Alaska Native (n = 1,640), Hispanic (n = 1,659), and non-Hispanic White (n = 2,537)]. Tissue blocks (1,594 tumor and 728 normal colon samples) were selected for 938 patients. To date, DNA and RNA have been extracted (n = 831), and tissue microarrays have been constructed (n = 414). Transcriptomic analysis, spatial tumor profiling (multiplex immunofluorescence, PhenoCycler, and GeoMx), and microbiome data (16S rRNA sequencing and digital droplet PCR) are available.

conclusionsThe TRPCDP has developed a clinically annotated biorepository for future molecular epidemiology studies. IMPACT: The TRPCDP is a unique program that supports collaborative research, community engagement, and pipeline development for the next generation of scientists.

Indexed as

Colorectal NeoplasmsTranslational Research, BiomedicalAgedCase-Control StudiesFemaleHumansMaleMiddle AgedUnited States

Identifiers

PMID40576634
PMCPMC12349377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.